RSS

Phase I

Danish biotech company, Acesion Pharma, has started the Phase I clinical study for its lead compound AP30663, which demonstrated a good safety profile and efficacy in converting AF to normal sinus rhythm in the preclinical development programme. more

Technology

A Phase I study is set to be initiated by OncoArendi Therapeutics to assess the safety, tolerability and pharmacokinetics of its lead compound and novel drug candidate, OATD-01 for the treatment of asthma. more

News

Hovione has announced the launch of its Phase I clinical trial of its minocycline sterile ointment, HY02, for the treatment of a subset of ocular surface inflammation. more

News

UK-based biotechnology company, ReViral, has announced top-line safety and pharmacokinetic (PK) data from the Phase I single and multiple ascending dose (SAD and MAD) trial of RV521. more

News

Approval has been granted for the third cohort of Prima BioMed’s Phase I clinical trial of IMP321 in combination with KEYTRUDA, being conducted in Australia. This cohort will recruit six patients with unresectable or metastatic melanoma. more

News

Kancera has applied for approval of a Phase I trial for its drug candidate, KAND567, which blocks the fractalkine system. The study will be performed in collaboration with the clinical contract company QPS in the Netherlands. more

News

Information has surfaced that suggests the drug, which caused the death of one person and the hospitalisation of five others, killed five dogs during a pre-clinical test more

News

One person has died and another five are in a serious condition after taking part in a French clinical drugs trial more

News

A £5.2 million ($8 million) milestone has been reached by Concert Pharmaceuticals and Celgene Corporation for the completion of a phase one clinical evaluation of CTP-730 more

News

This immunotherapy is designed to induce a robust immune response against Brachyury, a tumour-associated antigen which is overexpressed in every major solid tumour setting more